Intellia Therapeutics Inc buy Bank of America Co.
Start price
27.10.25
/
50%
€12.81
Target price
27.10.26
€25.78
Performance (%)
-20.37%
Price
08:42
€10.20
Summary
This prediction is currently active. The price of Intellia Therapeutics Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -20.37%. This prediction currently runs until 27.10.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | 5.993% | 5.993% |
| iShares Core DAX® | -1.875% | 2.861% |
| iShares Nasdaq 100 | -2.177% | 0.048% |
| iShares Nikkei 225® | -0.867% | 6.987% |
| iShares S&P 500 | -1.253% | 1.248% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NASDAQ:NTLA) had its price target lowered by analysts at Bank of America Corporation from $36.00 to $30.00. They now have a "buy" rating on the stock.
Ratings data for NTLA provided by MarketBeat